These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11885565

  • 1. Current issues in dendritic cell cancer immunotherapy.
    López JA, Hart DN.
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [Abstract] [Full Text] [Related]

  • 2. The use of dendritic cells for cancer vaccination.
    Esche C, Shurin MR, Lotze MT.
    Curr Opin Mol Ther; 1999 Feb; 1(1):72-81. PubMed ID: 11249687
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cells and their role in cancer immunotherapy.
    Jalili A.
    Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
    [Abstract] [Full Text] [Related]

  • 4. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.
    Tacken PJ, de Vries IJ, Torensma R, Figdor CG.
    Nat Rev Immunol; 2007 Oct; 7(10):790-802. PubMed ID: 17853902
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cell-based cancer therapy.
    Conrad C, Nestle FO.
    Curr Opin Mol Ther; 2003 Aug; 5(4):405-12. PubMed ID: 14513684
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cell-based immunotherapy.
    Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK.
    Int Rev Immunol; 2006 Aug; 25(5-6):377-413. PubMed ID: 17169781
    [Abstract] [Full Text] [Related]

  • 7. Cancer vaccines for established cancer: how to make them better?
    Andrews DM, Maraskovsky E, Smyth MJ.
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [Abstract] [Full Text] [Related]

  • 8. [Dendritic cells and their applications in cancer immunotherapy--achievements and future prospects].
    Rossowska J, Pajtasz-Piasecka E.
    Postepy Hig Med Dosw; 2003 Apr; 57(5):501-18. PubMed ID: 14737967
    [Abstract] [Full Text] [Related]

  • 9. Dendritic cells in cancer immunotherapy.
    Vulink A, Radford KJ, Melief C, Hart DN.
    Adv Cancer Res; 2008 Apr; 99():363-407. PubMed ID: 18037410
    [Abstract] [Full Text] [Related]

  • 10. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H, Shurin MR, Han B.
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cells as natural adjuvants.
    Citterio S, Rescigno M, Foti M, Granucci F, Aggujaro D, Gasperi C, Matyszak MK, Girolomoni G, Ricciardi-Castagnoli P.
    Methods; 1999 Sep; 19(1):142-7. PubMed ID: 10525450
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cell immunotherapy: mapping the way.
    Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ.
    Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cell-based cancer immunotherapies.
    Fujii S, Takayama T, Asakura M, Aki K, Fujimoto K, Shimizu K.
    Arch Immunol Ther Exp (Warsz); 2009 May; 57(3):189-98. PubMed ID: 19479202
    [Abstract] [Full Text] [Related]

  • 14. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S, Cochran AJ, Huang RR, Morton DL, Maecker HT.
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [Abstract] [Full Text] [Related]

  • 15. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S, Ueno H, Fay J, Banchereau J, Palucka AK.
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [Abstract] [Full Text] [Related]

  • 16. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 2004 Dec; 18(1):81-100. PubMed ID: 15011756
    [Abstract] [Full Text] [Related]

  • 17. Priming anticancer active specific immunotherapy with dendritic cells.
    Mocellin S.
    Curr Opin Investig Drugs; 2005 Jun; 6(6):576-81. PubMed ID: 15988908
    [Abstract] [Full Text] [Related]

  • 18. Dendritic cells in cancer immunotherapy.
    Schuler G.
    Eur J Immunol; 2010 Aug; 40(8):2123-30. PubMed ID: 20853498
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 20. Migration of dendritic cell based cancer vaccines: in vivo veritas?
    Adema GJ, de Vries IJ, Punt CJ, Figdor CG.
    Curr Opin Immunol; 2005 Apr; 17(2):170-4. PubMed ID: 15766677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.